After Hours Summary: HITI +18.2% sharply higher on earnings; PLAY -9.5% and DOMO -1.8% lower on earnings; Dell +0.4% ticks higher on Air Force award
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: HITI +18.2%,
Companies trading higher in after hours in reaction to news: ARI +2.2% (update on strategic alternatives; determined that the dissolution of the company is advisable), IPI +2% (names new CFO), HDRN +1.5% (stock offering; also stock offering by holders), MDLZ +1% (appoints new CFO), TLN +0.9% (completes acquisitions of Lawrenceburg Power Plant, Waterford Energy Center and Darby Generating Station), NBIX +0.4% (presents first retrospective case series of CRENESSIT; also presents new VYKAT XR data at ENDO 2026), DELL +0.4% (awarded $1.4 bln Air Force call order for the Microsoft Enterprise License Agreement renewal), CRK +0.3% (sold a minority interest in Pinnacle Gas Services for $600 mln), GROY +0.3% (additional interest in an existing royalty over the REN project), HPE +0.2% (advances quantum computing at scale with expanded industry collaborations), AMAT +0.2% (introduces two new chipmaking systems), NEM +0.2% (appoints new CFO and COO), VSTM +0.1% (to report updated data and progress across VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor TARGET-D Clinical Program), LMT +0.1% (awarded a $223.9 mln modification to Navy contract)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: PLAY -9.5%, DOMO -1.8% (also update on strategic alternatives)
Companies trading lower in after hours in reaction to news: ADPT -7.2% (convertible notes offering; also to pursue a separation of its Minimal Residual Disease and Immune Medicine businesses), NEO -5.4% (convertible notes offering), MAC -4% (stock offering), SFIX -3.5% (appoints new Chief Product and Technology Officer), LOVE -0.6% (appoints new CFO), QCOM -0.4% (in discussions to expand AI chip capabilities with potential Tenstorrent acquisition, according to The Information), SU -0.4% (files mixed securities shelf offering), GILD -0.3% (FDA accepts application for investigational once-weekly yeztugo), SSRM -0.1% (authorizes additional $500 mln for share repurchases)